Bernard Ravina
CIK 1711276 · View on SEC EDGAR ↗
First SEC filing: Oct. 15, 2020 · Latest: Oct. 15, 2020
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| April 10, 2018 | VYGR | S 10b5-1 | 2,451 | $18.38 | $45,049 | 0 Direct | -100.00% | Disposed | -81.7% (price as of 2026-08-20) |
| March 12, 2018 | VYGR | S 10b5-1 | 2,451 | $25.16 | $61,667 | 2,451 Direct | -50.00% | Disposed | -86.6% (price as of 2026-08-20) |
| Feb. 12, 2018 | VYGR | S 10b5-1 | 2,451 | $18.24 | $44,706 | 4,902 Direct | -33.33% | Disposed | -81.5% (price as of 2026-08-20) |
| Jan. 10, 2018 | VYGR | S 10b5-1 | 3,630 | $16.40 | $59,532 | 7,353 Direct | -33.05% | Disposed | -79.5% (price as of 2026-08-20) |
| Dec. 11, 2017 | VYGR | S 10b5-1 | 5,490 | $13.63 | $74,829 | 10,983 Direct | -33.33% | Disposed | -75.3% (price as of 2026-08-20) |
| Nov. 10, 2017 | VYGR | S 10b5-1 | 5,490 | $13.26 | $72,797 | 16,473 Direct | -25.00% | Disposed | -74.6% (price as of 2026-08-20) |
| Oct. 10, 2017 | VYGR | S 10b5-1 | 10,980 | $20.33 | $223,223 | 21,963 Direct | -33.33% | Disposed | -83.4% (price as of 2026-08-20) |
| Sept. 11, 2017 | VYGR | S 10b5-1 | 10,980 | $14.30 | $157,014 | 32,943 Direct | -25.00% | Disposed | -76.4% (price as of 2026-08-20) |
| Sept. 5, 2017 | VYGR | S 10b5-1 | 5,490 | $10.00 | $54,900 | 17,157 Direct | -24.24% | Disposed | -66.3% (price as of 2026-08-20) |
| July 20, 2017 | VYGR | S 10b5-1 | 5,490 | $10.00 | $54,900 | 49,413 Direct | -10.00% | Disposed | -66.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 7, 2022 | PRAX | Stock Option (Right to Buy) | Common Stock (77,000) | $18.11 | Jan. 7, 2032 | 77,000 | Acquired |
| March 7, 2018 | VYGR | Stock Option (Right to Buy) | Common Stock (65,000) | $28.72 | March 7, 2028 | 65,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 11 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Oct. 15, 2020 | PRAX | Common Stock | 11,021 | Direct |
| Oct. 15, 2020 | PRAX | Stock Option (Right to Buy)→ Common Stock (184,479) | 184,479 | Direct |
| Oct. 15, 2020 | PRAX | Stock Option (Right to Buy)→ Common Stock (80,507) | 80,507 | Direct |
| Oct. 15, 2020 | PRAX | Stock Option (Right to Buy)→ Common Stock (93,457) | 93,457 | Direct |
| July 7, 2017 | VYGR | Common Stock | 117,647 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (11,364) | 11,364 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (5,882) | 5,882 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (401) | 401 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (24,599) | 24,599 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (11,942) | 11,942 | Direct |
| July 7, 2017 | VYGR | Stock Options (Right to Buy)→ Common Stock (53,058) | 53,058 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2015 | $309,000 | $35,000 | — | $88,513 | $77,250 | — | — | $474,763 |
PRAX
M.D.Former Chief Medical Officer(5)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $287,249 | $416,667 | — | — | — | — | $402,314 | $2,763,754 |
| 2021 | $466,667 | — | — | — | $285,000 | — | $18,838 | $4,509,171 |
| 2020 | $425,000 | — | — | — | $357,000 | — | $17,813 | $1,711,010 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.